Acura Pharmaceuticals Inc (ACUR)
0.0025
0.00 (0.00%)
USD |
OTCM |
Mar 28, 16:00
Acura Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2017 | 95.29% |
December 31, 2016 | 96.23% |
September 30, 2016 | 50.46% |
June 30, 2016 | 61.48% |
March 31, 2016 | 54.46% |
December 31, 2015 | 96.19% |
September 30, 2015 | 37.14% |
June 30, 2015 | 71.26% |
March 31, 2015 | 93.95% |
December 31, 2014 | 92.63% |
September 30, 2014 | 25.52% |
June 30, 2014 | -20.00% |
March 31, 2014 | 9.52% |
December 31, 2013 | -2.86% |
September 30, 2013 | 6.02% |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 |
Date | Value |
---|---|
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | |
September 30, 2008 | |
June 30, 2008 | |
March 31, 2008 | |
December 31, 2007 | |
September 30, 2007 | |
June 30, 2007 | |
March 31, 2007 | |
December 31, 2006 | |
September 30, 2006 | |
June 30, 2006 | |
March 31, 2006 | |
December 31, 2005 | |
September 30, 2005 | |
June 30, 2005 | |
March 31, 2005 | |
December 31, 2004 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 56.29% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Ampio Pharmaceuticals Inc | -- |